Journal of Clinical & Experimental Ophthalmology · 2011 · 28 citations · 26 references
PLGA-based drug delivery systems are safe and non-inflammatory. They can be successfully used to treat ocular surface and corneal diseases by continuously delivering biopharmaceuticals of interest.
26